D-nopaline synthase
RxNorm 31951
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 31951 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: D-nopaline synthase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PT
Designated preferred name (PT):
D-nopaline dehydrogenase
(Atom ID: 11436244)
FN
Full form of descriptor (FN):
D-nopaline dehydrogenase (substance)
(Atom ID: 11436245)
SY
Synonym (SY):
D-nopaline synthase
(Atom ID: 11436246)
SY
Synonym (SY):
Nopaline dehydrogenase
(Atom ID: 11437799)
SY